Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CORV

Correvio Pharma (CORV) Stock Price, News & Analysis

About Correvio Pharma Stock (NASDAQ:CORV)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.42
50-Day Range
$0.39
$0.42
52-Week Range
$0.21
$2.79
Volume
N/A
Average Volume
5.35 million shs
Market Capitalization
$27.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CORV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Correvio Pharma and its competitors with MarketBeat's FREE daily newsletter.

CORV Stock News Headlines

Corvus Pharmaceuticals announces preclinical dataon soquelitinib
Corvus Pharmaceuticals options imply 17.7% move in share price post-earnings
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
An Overview of Corvus Pharma's Earnings
Atea Pharmaceuticals Advances in HCV Treatment Development
See More Headlines

CORV Stock Analysis - Frequently Asked Questions

Correvio Pharma Corp (NASDAQ:CORV) released its earnings results on Monday, March, 30th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $11.33 million for the quarter, compared to analysts' expectations of $11.52 million. Correvio Pharma had a negative trailing twelve-month return on equity of 2,128.82% and a negative net margin of 107.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Correvio Pharma investors own include Inovio Pharmaceuticals (INO), NightHawk Biosciences (NHWK), SCYNEXIS (SCYX), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), Oncobiologics (OTLK) and Vaxart (VXRT).

Company Calendar

Last Earnings
3/30/2020
Today
8/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CORV
CIK
N/A
Fax
N/A
Employees
133
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$35.18 million
Net Margins
-107.81%
Pretax Margin
N/A
Return on Equity
-2,128.82%
Return on Assets
-58.56%

Debt

Debt-to-Equity Ratio
22.54
Current Ratio
1.07
Quick Ratio
0.95

Sales & Book Value

Annual Sales
$32.63 million
Price / Sales
0.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-21.00

Miscellaneous

Outstanding Shares
66,191,000
Free Float
N/A
Market Cap
$27.80 million
Optionable
Optionable
Beta
0.08
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:CORV) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners